Table 1. Baseline characteristics of study subjects.
| No | Group | Sex | Age (months) | Body weight (kg) | Baseline rhythm | Lead |
|---|---|---|---|---|---|---|
| 1 | Drug-1 | Male | 12 | 32.1 | NSR | RA |
| 2 | Control-1 | Female | 15 | 29.0 | NSR | RAA |
| 3 | Drug-2 | Female | 24 | 28.2 | NSR | RAA |
| 4 | Sham-1 | Male | 24 | 24.3 | NSR | RAA |
| 5 | Drug-3 | Male | 12 | 25.1 | NSR | RAA |
| 6 | Sham-2 | Male | 24 | 22.6 | NSR | RAA |
| 7 | Control-2 | Male | 12 | 21.7 | NSR | RAA |
| 8 | Sham-3 | Female | 24 | 23.9 | NSR-nonsustained AF | RA |
| 9 | Drug-4 | Female | 24 | 25.5 | NRS-sinus bradycardia | RAA |
| 10 | Death | Male | 12 | 25.1 | NSR-sinus bradycardia | RAA |
| 11 | Sham-4 | Female | 36 | 31.2 | NSR | RAA |
| 12 | Control-3 | Femlae | 24 | 28.5 | NSR | RAA |
| 13 | Control-4 | Male | 15 | 31.2 | NSR | RAA |
NSR: normal sinus rhythm, RA: right atrium, RAA: right atrial appendage, AF: atrial fibrillation